Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;45(3):493-501.
doi: 10.1002/jimd.12469. Epub 2022 Jan 25.

Is the brain involved in patients with late-onset Pompe disease?

Affiliations

Is the brain involved in patients with late-onset Pompe disease?

Jan J A van den Dorpel et al. J Inherit Metab Dis. 2022 May.

Abstract

Our objective was to investigate brain structure, cerebral vasculature, and cognitive function in a cohort of patients with late-onset Pompe disease, with particular reference to the differences from those with the classic infantile phenotype, where extensive white-matter abnormalities (WMA) and impaired cognition on long-term enzyme treatment are reported in a subset of patients. Brain imaging (T1, T2, T2 fluid-attenuated inversion recovery, susceptibility-weighted images, and magnetic resonance angiography-time of flight) was combined with extensive cognitive testing of general intelligence (Wechsler IQ Test, Montreal Cognitive Assessment [MoCA]) and specific neuropsychological domains (verbal fluency, cognitive flexibility, attention, memory, and visuospatial abilities). We included 19 patients with late-onset Pompe disease (age range 11-56 years). Two patients showed mild punctate WMA within normal range for age, with a Fazekas score (FS) of 1 to 2. Magnetic resonance angiography revealed a slight vertebrobasilar dolichoectasia in two patients yet did not show any aneurysms or vascular dissections. Most patients had age-adjusted scores within the normal range for the Wechsler index scores (verbal comprehension, perceptual reasoning, working memory, and processing speed) and combined total intelligence (IQ) score (median 101, interquartile range 91-111; one patient had a below-average score for total IQ) as well as for the specific domains verbal fluency, attention, and memory. A subset of patients performed suboptimally on the Rey Complex Figure Test (9/14 patients) or cube-copying/clock-drawing test of the MoCA (8/10 patients). We therefore concluded that our study showed no brain abnormalities, other than minor microvascular lesions considered within normal range for age, nor general cognitive impairment in late-onset Pompe patients. These findings are in sharp contrast with the widespread WMA and cognitive problems found in some classic infantile patients.

Keywords: MRI brain imaging; Pompe disease; cognition; dolichoectasia; neuropsychological assessment; white-matter abnormalities.

PubMed Disclaimer

Conflict of interest statement

Jan J. A. van den Dorpel, Willemijn M. C. van der Vlugt, Marjolein H. G. Dremmen, Ryan Muetzel, Esther van den Berg, Roost Hest, Joni de Kriek, Esther Brusse, and Pieter A. van Doorn report no disclosures relevant to this manuscript. Ans T. van der Ploeg, Johanna M. P. van den Hout and Nadine A. M. E. van der Beek received funding for research, clinical trials, and as advisor from Sanofi Genzyme and Amicus Therapeutics under agreements with Erasmus MC University Medical Center.

Figures

FIGURE 1
FIGURE 1
Brain MRI and Rey complex figure test (RCFT) in late‐onset Pompe patients. A, T2 image, periventricular, and subcortical WM hyperintensities, Fazekas score 1 to 2 (patient 16). B, MRA‐TOF, vertobrobasilar dolichoectasia, diameter 4 mm (patient 18). C, RCFT template. D, Example of RCFT in which patient used a fragmented approach in figure copying. MRA‐TOF, Magnetic resonance angiography–time of flight; WM, white‐matter

References

    1. Kishnani PS, Hwu WL, Mandel H, et al. A retrospective, multinational, multicenter study on the natural history of infantile‐onset Pompe disease. J Pediatr. 2006;148:671‐676. - PubMed
    1. Reuser AJ, Hirschhorn R, Kroos MA. Pompe disease: glycogen storage disease type II, acid alpha‐glucosidase (acid maltase) deficiency. In: Valle D, Beaudet AL, Vogelstein B, eds. The Online Metabolic & Molecular Bases of Inherited Disease (OMMBID). New York: McGraw Hill; 2018. https://ommbid.mhmedical.com
    1. van den Hout HM, Hop W, van Diggelen OP, et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003;112:332‐340. - PubMed
    1. Ebbink BJ, Poelman E, Aarsen FK, et al. Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain. Dev Med Child Neurol. 2018;60:579‐586. - PubMed
    1. Korlimarla A, Spiridigliozzi GA, Crisp K, et al. Novel approaches to quantify CNS involvement in children with Pompe disease. Neurology. 2020;95:e718‐e732. - PMC - PubMed

Publication types